Cost-Benefit Analysis

Structured exercise rivals drug efficacy in slashing colon cancer recurrence and mortality

Survivors in a three-year, coach-led exercise arm experienced a 28% drop in recurrence and 37% fewer deaths, spurring experts to call for funded exercise integration in cancer care.